Nigeria Receives First Shipment of Breakthrough HIV Prevention Injection; 10 States Set for Rollout of Twice-Yearly ‘Lenacapavir’

Nigeria’s fight against HIV entered a “state of harmony” with modern science this week as the Federal Government took delivery of Lenacapavir, the world’s most advanced long-acting HIV prevention injection. The arrival of the shipment on Tuesday, March 10, 2026, marks a historic pivot from daily pill-taking to a convenient, twice-yearly injection that health experts say provides “near-total” protection against infection.

For years, the “Achilles’ heel” of Nigeria’s HIV prevention strategy has been adherence—the difficulty many at-risk individuals face in remembering to take a pill every single day. Lenacapavir “flips the script” by offering six months of continuous protection in a single dose. Approved by the Coordinating Minister of Health, Prof. Muhammad Ali Pate, and backed by the Global Fund, the drug is being hailed as a “game-changer” for young women and vulnerable groups who require discreet and effective protection.

“The arrival of Lenacapavir is a clear demonstration of Nigeria’s resolve to scale up innovative solutions,” stated Dr. Adebobola Bashorun, National Coordinator of the NASCP. While the drug carries a staggering $28,000 price tag in Western markets, Nigeria has secured access through a landmark global agreement that brings the cost down to just $40 a year, ensuring that this “breakthrough” isn’t just for the wealthy but for those who need it most.

Preparations for the first jabs are already in high gear. NASCP has completed readiness assessments in 10 states, including Lagos, Kano, and the FCT, where healthcare workers have been trained to integrate the injection into existing clinics. As the first vials are distributed to priority centers this month, Nigeria moves a massive step closer to its goal of ending the HIV epidemic by 2030, proving that sometimes, the best defense is simply a twice-yearly visit to the doctor.